NEW YORK, March 10 (GenomeWeb News) - Jubilant Biosys has licensed its PathArt database of manually curated pathways to French drug maker Fournier Pharma, the company said today.
Terms of the agreement were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.